Navigation Links
Generic drug costs remain shackled

Price controls for generic drugs in primary care are likely to remain unchanged for the next year as the european government considers how best to supply the NHS. In 1999, a severe shortage of non-brand name medicines resulted in a 12.5 per cent increase in the cost of prescription drugs for the NHS, significantly higher than the 8 per cent average increase in previous years. //

Pharmaceutical companies were accused of holding the NHS to ransom, and to protect the service from spiralling high prices the government began a maximum price scheme in August 2000. The measures had saved the NHS about £240 million during 2000 and 2001, and restored stability to the generics market. Under the European Directive the scheme must be reviewed within 12 months of its implementation.

The maximum price scheme would remain in force until a decision had been made on how best to supply generic medicines cost-effectively to the NHS. A spokesperson for the British Generic Manufacturers Association said the extension raised a number of issues. Continuing to base the controls on 1998 prices was likely to be painful, especially as a number of important products would be coming off patent next year. Department of Health figures show that last year 52 per cent of all dispensed prescriptions were for generic medicines.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Indian Generic Drug For AIDS Treatment
2. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
3. AIDS Generic Drugs Approved by FDA for Sale in US
4. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Generic Products Compete With GlaxoSmithKline
7. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. First Generic Version of Lexapro permitted by US
10. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
11. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a new 21st century approach to infusing high speed technology into the fabric ... exclusively dedicated to the advancement of healthcare and wellness in a yet-to-be-named, health ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... SC&H Group, a ... as a Principal in its IT Advisory Services practice . Rossi is the ... as market demand for strategic IT guidance grows, and the practice continues to expand.     ...
(Date:1/17/2017)... ... January 17, 2017 , ... Lynx Technology Partners ... US security companies for consecutive years, today announced the appointment of four members ... board nomination process to a close and positions Lynx for even faster growth ...
(Date:1/16/2017)... Creek, MI (PRWEB) , ... January 17, 2017 , ... ... abuse located in Southwest Michigan, joined other volunteers and organizations in support of the ... hundreds of children and families dressed up in colorful costumes of all designs coming ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017   Anesthesia Business Consultants ... practice management for the anesthesia and pain management ... remains a "clinical conundrum" (as described recently in ... practitioners to think carefully before recommending medical marijuana ... by the National Academies of Sciences, Engineering and ...
(Date:1/17/2017)... 17, 2017  In a preview of the upcoming Society ... Astute Medical, Inc., developer of the NephroCheck Test, today highlighted ... identifies hospital patients at risk of developing moderate to severe ... month at the Hawaii Convention Center ... January 25. AKI is one of the top ...
(Date:1/17/2017)... , January 17, 2017 OilPrice.com ... potentially earn millions in revenue with the planned upcoming ... numbers of strokes with a simple test that is ... with latest developments in the markets today include:  Amgen ... AZN ), Cancer Genetics, Inc. (NASDAQ: ...
Breaking Medicine Technology: